Clinical practice guideline for female fertility preservation.

ABSTRACT:

Introduction

Female fertility preservation (FFP) has become a clinical priority because gonadotoxic therapies for cancer and benign diseases are increasingly common and may cause irreversible ovarian failure. The current clinical practice guideline provides evidence-based recommendations on fertility assessment, oocyte/embryo cryopreservation, and ovarian tissue cryopreservation and transplantation for women at risk of iatrogenic infertility.

Methods

This guideline was developed in accordance with the WHO Handbook for Guideline Development. A multidisciplinary Guideline Development Group (GDG) formulated nine key clinical questions in the field of FFP, and Cochrane-standard systematic reviews were conducted for each question. The certainty of the evidence was assessed using

SUBMITTER: Sun N 

PROVIDER: S-EPMC12907358 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature